Skip to main content
Clinical Trials/JPRN-UMIN000038675
JPRN-UMIN000038675
Recruiting
未知

Observation of changes in ocular findings before and after the use of the IL-4 and 13 antibody preparation dupilumab - dupilumab

Keio University0 sites150 target enrollmentNovember 26, 2019

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Keio University
Enrollment
150
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 26, 2019
End Date
March 31, 2024
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Patients who have refused to provide clinical information to this study

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Not Applicable
Visual disturbances of patients following operatioHealth Condition 1: O- Medical and Surgical
CTRI/2023/03/050562GCS medical college and hospital
Terminated
Not Applicable
Changes in ocular mucin expression due to contact lens wear
ACTRN12609000447257Institute for Eye Research30
Completed
Not Applicable
Observation of changes in ocular structural and functional parameters before and after steep Trendelenburg positioning during robotic-assisted laparoscopic radical prostatectomy (RALP)prostatic cancer
JPRN-UMIN000022492Department of Ophthalmology Aichi Medical University20
Active, not recruiting
Phase 1
A clinical trial on the changes in ocular signs and symptoms in patientswith ocular hypertension or open-angle glaucoma switched from Ganfort® eye drops to Taptiqom® eye drops.Glaucoma or Ocular HypertensionMedDRA version: 18.0Level: HLGTClassification code 10018307Term: Glaucoma and ocular hypertensionSystem Organ Class: 10015919 - Eye disordersMedDRA version: 18.0Level: PTClassification code 10030348Term: Open angle glaucomaSystem Organ Class: 10015919 - Eye disordersMedDRA version: 18.0Level: PTClassification code 10074026Term: Exfoliation glaucomaSystem Organ Class: 10015919 - Eye disordersTherapeutic area: Diseases [C] - Eye Diseases [C11]
EUCTR2014-005273-37-DESanten Oy120
Active, not recruiting
Phase 1
A clinical trial on the changes in ocular signs and symptoms in patientswith ocular hypertension or open-angle glaucoma switched from Ganfort® eye drops to Taptiqom® eye drops.Glaucoma or Ocular HypertensionMedDRA version: 17.1Level: HLGTClassification code 10018307Term: Glaucoma and ocular hypertensionSystem Organ Class: 10015919 - Eye disordersMedDRA version: 17.1Level: PTClassification code 10030348Term: Open angle glaucomaSystem Organ Class: 10015919 - Eye disordersMedDRA version: 17.1Level: PTClassification code 10074026Term: Exfoliation glaucomaSystem Organ Class: 10015919 - Eye disordersTherapeutic area: Diseases [C] - Eye Diseases [C11]
EUCTR2014-005273-37-FISanten Oy120